Tag: Obe-Cel approval for B-Cell Acute Lymphoblastic Leukemia

The FDA has approved a new treatment for patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). This treatment, called obecabtagene autoleucel (obe-cel),...